🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

11,276 results for “Te” Clear

  1. Lenabasum 5 mg

    Corbus Pharmaceuticals Holdings

    Diffuse Cutaneous Systemic Sclerosis

    phase 3 small molecule terminated

    1 trial

  2. Lenalidomide

    Celgene Europe Limited

    B-cell Chronic Lymphocytic Leukemia

    phase 3 small molecule completed

    1 trial

  3. Lenvatinib, Belzutifan, Lenvatinib

    Merck Sharp and Dohme

    Renal Cell Carcinoma, hepatocellular carcinoma, nonMSI-H/dMMR colorectal cancer, pancreatic ductal adenocarcinoma, biliary tract cancer, non-MSIH/dMMR endometrial cancer, esophageal squamous cell carcinoma, Advanced Pheochromocytoma/Paraganglioma, Pancreatic Neuroendocrine Tumor, von Hippel-Lindau (VHL)Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor, Advanced Solid Tumors With HIF-2α related Genetic Alterations

    phase 3 small molecule active

    1 trial

  4. Leuprorelin

    Takeda

    Prostate Cancer

    phase 3 small molecule completed

    1 trial

  5. Levamlodipine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hypertension

    phase 3 small molecule completed

    1 trial

  6. Levetiracetam NORMON 250 mg comprimidos recubiertos con película EFG, PLACEBO LEVETIRACETAM 250 mg, Levetiracetam NORMON 500 mg comprimidos recubiertos con película EFG, PLACEBO LEVETIRACETAM 500 mg

    The George Institute

    Down syndrome, Alzheimer's Disease

    phase 3 small molecule active

    1 trial

  7. Levetiracetam XR, Masked Keppra® placebo film-coated tablets (a placebo tablet inside a capsule), Keppra 500 mg film-coated tablets, Levetiracetam prolonged-release placebo granules

    NEURAXPHARM AUSTRALIA PTY LIMITED

    Refractory Partial Onset Epilepsy

    phase 3 small molecule active

    1 trial

  8. Levodopa

    Lxo Ireland Designated Activity Company

    Ischaemic Stroke

    phase 3 small molecule completed

    1 trial

  9. Levodopa-Carbidopa Intestinal Gel (LCIG)

    AbbVie

    Advanced Parkinson's Disease

    phase 3 small molecule completed

    1 trial

  10. Levonorgestrel/EE 0.15/0.03 mg and EE 0.01 mg tablets

    Teva Pharma GmbH

    Contraception

    phase 3 small molecule completed

    1 trial

  11. Levosimendan

    TENAX THERAPEUTICS, INC.

    Coronary Artery Bypass Grafting

    phase 3 small molecule completed

    1 trial

  12. Levosimendan, The levosimendan placebo drug product is an immediate-release dosage form for oral administration.

    TENAX THERAPEUTICS, INC.

    Pulmonary Hypertension (PH) with Heart Failure with preserved left ventricular ejection fraction (PH-HFpEF)

    phase 3 small molecule active

    1 trial

  13. Levotiroxina Teva 25 microgrammi compresse

    Fondazione Telethon ETS

    Hodgkin and non Hodgkin lymphoma, Medulloblastoma

    phase 3 small molecule active

    1 trial

  14. Lidocaine spray

    Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co.,

    Uterine Cervical Dysplasia

    phase 3 other completed

    1 trial

  15. Lidocaine spray

    Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co.,

    Uterine Bleeding

    phase 3 small molecule completed

    1 trial

  16. Lifestyle modification

    Takeda

    Type 2 Diabetes

    phase 3 other completed

    1 trial

  17. Lifitegrast

    Takeda

    Keratoconjunctivitis Sicca

    phase 3 small molecule completed

    1 trial

  18. Lifitegrast

    Takeda

    Dry Eye Disease

    phase 3 small molecule completed

    3 trials

  19. Linaclotide 290 micrograms

    IRONWOOD PHARMACEUTICALS INC

    Irritable Bowel Syndrome Characterized by Constipation

    phase 3 small molecule completed

    1 trial

  20. Linagliptin

    Boehringer Ingelheim

    Diabetes Mellitus, Type 2

    phase 3 small molecule completed

    3 trials

  21. Linvoseltamab

    Regeneron UK Limited

    High Risk Smoldering Multiple Myeloma (HR-SMM)

    phase 3 small molecule active

    1 trial

  22. Linvoseltamab

    Regeneron UK Limited

    Relapsed and/or Refractory Multiple Myeloma (RRMM)

    phase 3 small molecule active

    1 trial

  23. Linvoseltamab

    Regeneron UK Limited

    Multiple Myeloma

    phase 3 small molecule active

    6 trials

  24. Linvoseltamab

    Regeneron UK Limited

    Multiple Myeloma (MM)

    phase 3 small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources